Business Wire

Citrusbyte Announces Global Rebrand to Theorem

Share

Citrusbyte, a leading provider of innovation and engineering services to the Fortune 500, announces that beginning today, the company will operate under the new brand name Theorem. The new name for the firm reflects a realignment of the company’s brand with its long-term vision and strategy for delivering transformative innovation services to the world’s biggest enterprises.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190319005008/en/

New Theorem logo (Photo: Business Wire)

New Theorem logo (Photo: Business Wire)

“The Theorem name represents the company that we have built over the last 12 years. This isn’t a redefinition of who we are — it is about ensuring our brand accurately reflects what we have become. Our focus on people and culture as the fundamental drivers of business innovation is reflected in our new identity,” said Brady Brim-DeForest, Theorem CEO. “The Theorem name is about reconnecting with the mathematical, computer science driven DNA of our organization and it elegantly captures our iterative, hypothesis-driven process.”

Theorem is a new kind of consulting company built for a world where the only constant is change. It supports its customers in innovation, design, instrumentation, development, and launch of solutions to complex problems powered by a combination of technology, people, passion, and the scientific process. Select clients include American Express, Apple, AT&T, Caterpillar, First American, and Google.

In addition to the new brand name, the company will be rolling out a comprehensive update to its visual identity system complete with a new logo and new website.

“Our brand has been built on quality, expertise, and craftsmanship – we pride ourselves on building long-term relationships with the world’s most innovation-forward organizations,” said Will Jessup, Founder and Head of Services Delivery. “Our new identity only reinforces the core values that drive our business forward, and our customers will still receive the same great, partnership-oriented experience they always have.”

Also being announced today is the company’s new Strategic Innovation Partner program that will expand and grow its complementary and supplementary service offerings with new, robust tools from partners that will help attract, bring value to, and monetize new and existing opportunities. Theorem’s Strategic Innovation Partner program targets participation from technology service providers, specialized software firms, and vertical specific experts.

About Theorem

Theorem (previously Citrusbyte) is an innovation and engineering company that advises clients on product strategy, engineering, design, and culture, then partners with them to build and launch technology-driven solutions to their most complex problems. Theorem is chosen by clients when results matter most — becoming the agent of change, and driving a transformation that involves not only technology, but also people, process and leadership. Founded in 2007, and headquartered in Los Angeles, Theorem's global team of engineers, designers, technologists, researchers, strategists, and advisors, has deep expertise across a broad variety of industries including consumer electronics, automotive, manufacturing, supply chain, healthcare, finance, and entertainment. To learn more, visit: www.theorem.co.

Contact information

Andrew Upah
Theorem Public Relations
press@theorem.co

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Knopp Biosciences Announces Start of Phase 2 Clinical Trial Evaluating Oral Dexpramipexole in Moderate-to-Severe Eosinophilic Asthma19.8.2019 10:00:00 CESTPress release

Knopp Biosciences LLC today announced the start of Phase 2 dose-ranging clinical trial in moderate-to-severe eosinophilic asthma. Recruitment in the trial is underway and the first patient has been enrolled. The Company anticipates reporting top-line data from this trial in the second half of 2020. This 12-week biomarker study is planned to randomize approximately 100 patients with eosinophilic asthma to investigate the eosinophil response to three different doses of oral dexpramipexole. The primary outcome measure of this randomized, double-blind, placebo-controlled study is the change in blood absolute eosinophil count from Baseline to Week 12. The secondary outcome measures include changes in pre-bronchodilator FEV1 and asthma control outcomes (ACQ-7 questionnaire) from baseline to week 12. “We estimate that there are more than two million moderate-to-severe eosinophilic asthma patients in the U.S. and are excited about further characterizing the clinical profile of oral dexpramipex

CES Unveiled in Amsterdam to Showcase Tech for Good19.8.2019 07:00:00 CESTPress release

Consumer Technology Association (CTA): WHAT: The Consumer Technology Association (CTA)® today announced several government officials, dignitaries and industry leaders attending CES Unveiled in Amsterdam, an official CES preview event, focusing on the theme “Tech for Good.” Returning for its third year, CES Unveiled in Amsterdam will bring together executives, influential media, prominent industry influencers, and more than 100 companies (including 50+ startups) to explore the latest technology trends and innovations from the Netherlands and surrounding European countries leading up to CES® 2020. Attendees and media are able to register for CES Unveiled in Amsterdam online. WHO: Government officials and dignitaries including Mona Keijzer, Netherlands State Secretary for Economic Affairs and Climate Policy; HRH Prince Constantijn van Oranje, Special Envoy at TechLeap.NL; and Pete Hoekstra, U.S. Ambassador to the Netherlands, will share insights on emerging trends in the industry, includi

RISO Unveils VALEZUS, a New Brand for the Production-printing Market19.8.2019 06:00:00 CESTPress release

RISO KAGAKU CORPORATION (President & CEO: Akira Hayama; hereinafter “RISO”) announced today the launch of VALEZUS, a new brand of high-speed ink-jet printers for the production-printing market. RISO will start with successive rollouts worldwide of the new brand’s first product, the VALEZUS T2100, a high-speed, 320-page-per-minute (320-ppm) cut-sheet printer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190818005001/en/ 1 The new brand, VALEZUS One of RISO’s commanding strengths is the development of inks optimized for high-speed paper feeding and high-speed printing. This expertise enables RISO to deliver unique printing solutions serving the demand for high-volume printing. With technologies developed and cultivated in this field, RISO launches the VALEZUS, a fresh brand targeting the production-printing market. 2 The all-new VALEZUS T2100 VALEZUS T2100 The first product of the new brand, the VALEZUS T2100 is a high-speed

Velodyne Files Patent Infringement Complaint with ITC Against Hesai and RoboSense16.8.2019 12:00:00 CESTPress release

Velodyne Lidar, Inc. filed a patent infringement complaint with the U.S. International Trade Commission (ITC) against Hesai Photonics Technology Co., Ltd. and Suteng Innovation Technology Co., Ltd. (a.k.a. RoboSense) for violations of section 337 of the Tariff Act of 1930 which makes unfair methods of competition and importation of certain products into the United States unlawful. Earlier this week, Velodyne also filed patent infringement complaints against Hesai and RoboSense in the U.S. District Court for the Northern District of California. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190816005041/en/ Velodyne Lidar’s Alpha Puck™, Ultra Puck™ and Puck™ surround view sensors (left to right). (Photo: Business Wire) Velodyne is asking the ITC to investigate these lidar manufacturers for unlawfully importing and selling lidar sensors that infringe Velodyne’s patented lidar technology (U.S. Patent 7,969,558). Velodyne reques

Merz Announces Key Governance Changes16.8.2019 09:26:00 CESTPress release

Merz, a global leader in medical aesthetics and specialty neurology, announced today that Philip Burchard will be appointed Chairman of the company’s Shareholders Council. He will assume this role in addition to his current position as Chief Executive Officer of the Merz Healthcare Group. In his new position, Philip Burchard will succeed Andreas Krebs, who has decided to step down from his current roles as Chairman of the Shareholders Council and Supervisory Board of Merz in order to dedicate more time to his personal entrepreneurial and philanthropic activities. In addition, Dr. Christian Holzherr will be the new Chairman of the Merz Supervisory Board. All changes will be effective as of October 31, 2019. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190816005106/en/ Philip Burchard, CEO of Merz (Photo: Business Wire) Philip Burchard joined Merz as CEO in July 2012. Under his leadership, Merz has focused its strategy on ae

FINEOS lists on the Australian Securities Exchange16.8.2019 07:22:00 CESTPress release

FINEOS Corporation Holdings plc (ASX:FCL), a leading provider of group and individual core systems for life, accident and health insurance, today announced the commencement of trading on the Australian Securities Exchange (ASX) via an initial public offering (IPO). The total number of securities (CHESS Depository Interests or “CDIs”) on offer was 84.4 million at a price of A$2.50 per CDI. Total gross proceeds from the offer amounted to A$211 million. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190816005058/en/ FINEOS lists on the Australian Securities Exchange (Photo: Business Wire) FINEOS intends to use the net proceeds from the IPO to invest further in R&D to grow the FINEOS product footprint and develop new business lines, to invest in additional sales, marketing and client account management capabilities and to pay down existing debt and shareholders selling down. Key areas of growth strategy for FINEOS include: • Inc